Failure of lipopolysaccharides to directly trigger the chemiluminescence response of isolated equine polymorphonuclear leukocytes

Veterinary Research Communications

Volumn 21, Issue 7, 1997, Pages 477-482

  Benbarek, H ^a   Deby Dupont, G ^a   Caudron, I ^a   Deby, C ^a   Lamy, M ^a   Serteyn, D ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chemiluminescence; Endotoxin; Horse; Lipopolysaccharide; Neutrophil; Oxygen; Plasma

Indexed keywords

LIPOPOLYSACCHARIDE; LUMINOL;

ANIMAL; ARTICLE; BLOOD; CHEMOLUMINESCENCE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ESCHERICHIA COLI; HORSE; METABOLISM; NEUTROPHIL; PHYSIOLOGY; PLASMA;

ANIMALS; CHEMILUMINESCENT MEASUREMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; HORSES; LIPOPOLYSACCHARIDES; LUMINOL; NEUTROPHILS; PLASMA;

EID: 0031243562     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005938319482     Document Type: Article

References (25)

1. Allred, C.D. and Hill, H.R., 1978. Effects of chemoattractants on chemiluminescence. Infection and Immunity, 19, 833-838
2. Babior, B.M., 1978. Oxygen dependent microbial killing by phagocytes. New England Journal of Medicine, 298, 659-668 and 721-725
3. Benbarek, H., Deby-Dupont, G., Deby, C., Caudron, I., Mathy-Hartert, M., Lamy, M. and Serteyn, D., 1996. An experimental model based on chemiluminescence for the study of the activation of isolated equine leukocytes. Research in Veterinary Science, 61, 59-64
4. Berczi, I., Bertók, L. and Bereznai, T., 1966. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Canadian Journal of Microbiology, 12 1070-1071
5. Beswick, P.H. and Kay, A.B., 1981. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of eosinophils and neutrophils. Clinical and Experimental Immunology, 43, 399-407
6. Bochsler, P.N., Slauson, D.O. and Neilson, N.R., 1992. Secretory activity of equine polymorphonuclear leucocytes: stimulus specificity and priming effects of bacterial lipopolysaccharide. Veterinary Immunology and Immunopathology, 31, 241-253
7. Burrows, G.E., 1981. Dose-response of ponies to parenteral Escherichia coli endotoxin. Canadian Journal of Comparative Medicine, 45, 207-210
8. Cooper, N.R. and Morrison, D.C., 1978. Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. Journal of Immunology, 120, 1862-1868
9. Dorn, C.R., Coffman, J.R., Schmidt, D.A., Garner, H.E., Addison, J.B. and McCune, E.L., 1975. Neutropenia and salmonellosis in hospitalized horses. Journal of the American Veterinary Medical Association, 166, 65-67
10. Easmon, C.S.F., Cole, P.J., Williams, A.J. and Hastings, M., 1980. The measurement of opsonic and phagocytic function by luminol-dependent chemiluminescence. Immunology, 41, 67-74.
11. Fujishima, S. and Aikawa, N., 1995. Neutrophil-mediated tissue injury and its modulation. Intensive Care Medicine, 21, 277-285
12. Henricks, P.A.J., Van der Tol, M.E., Thyssen, R.M.W.M., Van Asbeck, B.S. and Verhoof, J., 1983. Escherichia coli lipopolysaccharides diminish and enhance cell function of polymorphonuclear leukocytes. Infection and Immunity, 41, 294-301
13. Hunt, R.J., Allen, D. and Moore, J.N., 1990. Effect of endotoxin administration on equine digital hemodynamics and starling forces. American Journal of Veterinary Research, 51, 1703-1707
14. Johnston, R.B., Keele, B.B., Misra, H.P., Lehmeyer, V.L., Webb, L.S., Baehner, R.L. and Rajagopalan, K.V., 1975. The role of Superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. Journal of Clinical Investigation, 55, 1357-1372
15. Meyers, K., Reed, S., Keck, M., Clem, M. and Baily, W., 1982. Circulating endotoxin-like substance(s) and altered hemostasis in horse with gastrointestinal disorders: an interim report. American Journal of Veterinary Research, 43, 2233-2238
16. Morrison, D.C. and Kline, L.F., 1977. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharide (LPS). Journal of Immunology, 118, 362-368
17. Nicotra, J., Orsini, A.J. and DeBari, V.A., 1985. Chemiluminescence response of the human polymorphonuclear neutrophil to lipopolysaccharides. Cellular Biophysics, 7, 283-291
18. Proctor, R.A., 1979. Endotoxin in vitro interactions with human neutrophils: depression of chemiluminescence, oxygen consumption, Superoxide production, and killing. Infection and Immunity, 25, 912-921
19. Pycock, J.F., Allen W.E. and Morris, T.H., 1987. Rapid, single-step isolation of equine neutrophils on a discontinuous Percoll density gradient. Research in Veterinary Science, 42, 411-412
20. Seethanathan, P., Bottoms, G.D. and Schafer, K., 1990. Characterization of release of tumor necrosis factor, interleukin-1, and Superoxide anion from equine white blood cells in response to endotoxin. American Journal of Veterinary Research, 51, 1221-1225
21. Ward, D.S., Fessler, J.F., Bottoms, G.D. and Turek, J., 1987. Equine endotoxemia: cardiovascular, eicosanoid, hematologic, blood chemical, and plasma enzyme alterations. American Journal of Veterinary Research, 48, 1150-1156
22. Webster, R.O., Hong, S.R., Johnston, R.B. Jr. and Henson, P.M., 1980. Biological effects of the human complement fragments C5a and C5a desarg on neutrophil function. Immunopharmacology, 2, 201-219
23. Wilson, M.E., Jones, D.P., Munkenbeck, P. and Morrison, D.C., 1982. Serum-dependent and independent effects of bacterial lipopolysaccharides on human neutrophil oxidative capacity in vitro. Journal of the Reticuloendothelial Society, 31, 43-57
24. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J. and Mathison, J.C., 1990. CD-14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science, 249, 1431-1433
25. 2 release and chemiluminescence. Journal of Cellular Physiology, 146, 264-269